Prime Medicine, Inc. Common Stock
€2.543
EUR
Last updated on --.
24h volume2.13M
24h highest2.6466 EUR
24h lowest2.4877 EUR
24h Price movement-0.34%
PRME recent prices
24 Hours
-0.34%-€0.008593
30 days
-19.35%-€0.6101
60 days
-12.72%-€0.3695
90 days
-32.42%-€1.221
Key data
Previous close2.5521 EUR
Market cap439.23M EUR
Volume2.13M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount0.68744 EUR
Next ex-dividend dateSep 10, 2019
Next payment dateSep 12, 2019
EPS diluted (TTM)-0.94523 EUR
Net income (FY)-170.46M EUR
Revenue (FY)3.47M EUR
Last report dateMay 7, 2026
About Prime Medicine, Inc. Common Stock
HeadquartersCAMBRIDGE
Employees (FY)146.00
Revenue per employee (FY)23.74K EUR
Net income per employee (FY)-1.17M EUR
Listed onNasdaq
PRME conversion tables
 |  |
|---|---|
| 0.5 PRME | 1.271 EUR |
| 1 PRME | 2.543 EUR |
| 5 PRME | 12.71 EUR |
| 10 PRME | 25.43 EUR |
| |
|---|---|
| 0.5 EUR | 0.19658 PRME |
| 1 EUR | 0.39315 PRME |
| 5 EUR | 1.965 PRME |
| 10 EUR | 3.931 PRME |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
PRME is trading at €2.543, -0.34% over the last 24 hours. Track live moves on the price chart at the top of this page.
The PRME stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. PRME is currently trading at €2.543, -0.34% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on PRME price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. PRME's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from PRME; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against PRME's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Prime Medicine, Inc. Common Stock's market cap is currently 439.23M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.13M
24h highest2.6466 EUR
24h lowest2.4877 EUR
24h Price movement-0.34%
Start trade with PRME Perpetual
Sign up to trade